Organisation paid for research Program year 2022 Source: CMS Open Payments

Sterling Research Group Ltd

Neither a doctor nor a teaching hospital

Research payments

$987,737

146 payments

Through program year 2022, Sterling Research Group Ltd is reported as receiving $987,737 in research payments, across 146 payments.

By program year

4 rows
Year Kind Amount Payments
2022 Research $30,807 2
2021 Research $158,204 32
2020 Research $200,154 32
2019 Research $598,572 80

Breakdown

Who paid Research payments · program years 2019–2022
  1. Pfizer Inc. $917,122 129 payments
  2. Novartis Pharmaceuticals Corporation $28,081 3 payments
  3. Akcea Therapeutics, Inc. $21,074 11 payments
  4. GlaxoSmithKline, LLC. $9,434 1 payment
  5. Adaptive Biotechnologies Corporation $7,026 1 payment
  6. Aerie Pharmaceuticals, Inc. $5,000 1 payment
Studies the money was for Research payments · program years 2019–2022
  1. A Phase 3 Randomized Doubleblind Trial to Evaluate the Safety and Immunogenicity of A 20Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccinenaive Adults 18 Years of Age and Older $428,287 37 payments
  2. A Phase 12 Placebocontrolled Randomized Observerblind Dosefinding Firstinhuman Study to Describe the Safety Tolerability and Immunogenicity of A Respiratory Syncytial Virus RSV Vaccine in Healthy Adults $142,893 15 payments
  3. A Phase 3 Randomized Doubleblind Trial to Evaluate the Safety and Immunogenicity of A 20Valent Pneumococcal Conjugate Vaccine 20Vpnc When Coadministered With Seasonal Inactivated Influenza Vaccine Siiv in Adults 65 Years of Age $99,818 13 payments
  4. A 12Week Phase 2A Randomized Doubleblind Sponsoropen Placebocontrolled Parallel Group Study to Assess the Safety Tolerability and Pharmacodynamics of Pf06882961 Titration in Adults With Type 2 Diabetes Mellitus Treated With Metformin and in Nondiabetic Adults With Obesity $87,300 16 payments
  5. A Phase 3 Randomized Openlabel Trial to Evaluate the Safety and Immunogenicity of A 20Valent Pneumococcal Conjugate Vaccine in Adults 65 Years of Age With Prior Pneumococcal Vaccination $59,143 14 payments
  6. A Phase 2A Randomized Double Blind Sponsoropen Placebo Controlled Parallel Group Study to Assess the Pharmacodynamics Safety and Tolerability of Pf05221304 and Pf06865571 Coadministered for 6 Weeks in Adults With Nonalcoholic Fatty Liver Disease Nafld $39,147 5 payments
  7. An Open-Label Extension Trial of the Phase III Lipid-Lowering Trials to Assess the Effect of Long Term Dosing of Inclisiran Given As Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated LDL-C $28,081 3 payments
  8. A Phase 2A 2Part Randomized Doubleblind Doubledummy Placebocontrolled Parallelgroup Sponsor Open Study to Assess Pharmacodynamics and Safety of Pf06865571 Dgat2i Coadministered With Pf05221304 Acci in Adult Participants With Presumed Nonalcoholic Steatohepatitis Nash $27,781 5 payments
  9. A Phase 2A Randomized Doubleblind Placebocontrolled 3Arm Parallel Group Study to Evaluate the Safety Tolerability and Pharmacodynamics of Pf06835919 Administered Once Daily for 6 Weeks in Adults With Nonalcoholic Fatty Liver Disease $17,157 1 payment
  10. Isis 703802-Cs2 $10,800 1 payment
What the money was spent on Research payments · program years 2019–2022
  1. Other $7,026 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record